


To provide a high and stable income, with the prospect of capital and income growth over the long term.This Fund is made up of around 70% UK equities and 30% UK investment grade bonds, A and AA rated.
| Name | % Net Assets |
|---|---|
| Royal Dutch Shell | 6.7% |
| BP | 6.3% |
| GlaxoSmithKline | 4.1% |
| HSBC | 3.8% |
| AstraZeneca | 3.6% |
| Vodafone | 3.0% |
| British American Tobacco | 2.9% |
| Unilever | 2.4% |
| BHP Billiton | 2.3% |
| BG Group | 1.7% |
| Key | % Net Assets |
|---|---|
| 6.7% | |
| 6.3% | |
| 4.1% | |
| 3.8% | |
| 79.1% |
| Date | 15-Dec-2017 |
|---|---|
| NAV | 90.29p |
| Currency | GBP |
| Change | -0.48p |
| % | -0.53% |
| YTD change | 90.29p |
| YTD % | n/a |
| Fund Inception | 01/10/1994 |
|---|---|
| Fund Manager | Jamie Streeter / James Illsley / Talib Sheikh |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £100 |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 3.50% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.07 |
You are here: research